Net profit of Biofil Chemicals & Pharmaceuticals declined 10.00% to Rs 0.09 crore in the quarter ended December 2023 as against Rs 0.10 crore during the previous quarter ended December 2022. Sales rose 237.58% to Rs 5.03 crore in the quarter ended December 2023 as against Rs 1.49 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales5.031.49 238 OPM %3.7815.44 - PBDT0.220.24 -8 PBT0.110.13 -15 NP0.090.10 -10 Powered by Capital Market - Live News

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 February 2024.Powered by Capital Market - Live News

Net profit of Biofil Chemicals & Pharmaceuticals rose 140.00% to Rs 0.12 crore in the quarter ended September 2023 as against Rs 0.05 crore during the previous quarter ended September 2022. Sales rose 562.98% to Rs 17.37 crore in the quarter ended September 2023 as against Rs 2.62 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales17.372.62 563 OPM %1.386.49 - PBDT0.260.18 44 PBT0.150.07 114 NP0.120.05 140 Powered by Capital Market - Live News

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 2023.Powered by Capital Market - Live News

Biofil Chemicals & Pharmaceuticals announced that the 38th Annual General Meeting (AGM) of the company will be held on 27 September 2023.Powered by Capital Market - Live News